Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 16;8(7):728.
doi: 10.3390/cells8070728.

Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects

Giuseppe Paradies  1 , Valeria Paradies  2 , Francesca M Ruggiero  3 , Giuseppe Petrosillo  4
Affiliations
Review

Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects

Giuseppe Paradies et al. Cells. .

Abstract

In eukaryotic cells, mitochondria are involved in a large array of metabolic and bioenergetic processes that are vital for cell survival. Phospholipids are the main building blocks of mitochondrial membranes. Cardiolipin (CL) is a unique phospholipid which is localized and synthesized in the inner mitochondrial membrane (IMM). It is now widely accepted that CL plays a central role in many reactions and processes involved in mitochondrial function and dynamics. Cardiolipin interacts with and is required for optimal activity of several IMM proteins, including the enzyme complexes of the electron transport chain (ETC) and ATP production and for their organization into supercomplexes. Moreover, CL plays an important role in mitochondrial membrane morphology, stability and dynamics, in mitochondrial biogenesis and protein import, in mitophagy, and in different mitochondrial steps of the apoptotic process. It is conceivable that abnormalities in CL content, composition and level of oxidation may negatively impact mitochondrial function and dynamics, with important implications in a variety of pathophysiological situations and diseases. In this review, we focus on the role played by CL in mitochondrial function and dynamics in health and diseases and on the potential of pharmacological modulation of CL through several agents in attenuating mitochondrial dysfunction.

Keywords: Cardiolipin; mitochondrial structure-function; pharmacological agents; physiopathology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Proposed roles of cardiolipin in mitochondrial function and dynamics. Cyt c, cytochrome c; ETC, electron transport chain; IMM, inner mitochondrial membrane; mPTP, mitochondrial permeability transition pore. For details, see the text.
Figure 2
Figure 2
Proposed role for cardiolipin in ATP synthasome formation and mPTP opening. ANT, adenine nucleotide translocator; CL, cardiolipin; CLox, oxidized cardiolipin; Cyp D, cyclophilin D; IMM, inner mitochondrial membrane; mPTP, mitochondrial permeability transition pore; PiC, phosphate carrier. For details, see the text.
Figure 3
Figure 3
Cardiolipin abnormalities in diseases. I/R, ischemia/reperfusion, ROS, reactive oxygen species. For details, see the text.
Figure 4
Figure 4
Cardiolipin as target for pharmacological intervention in disease. ETC, electron transport chain; OXPHOS, oxidative phosphorylation; ROS, reactive oxygen species. For details, see the text.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Osellame L.D., Blacker T.S., Duchen M.R. Cellular and molecular mechanisms of mitochondrial function. Best Pr. Res. Clin. Endocrinol. Metab. 2012;26:711–723. doi: 10.1016/j.beem.2012.05.003. - DOI - PMC - PubMed
    1. Horvath S.E., Daum G. Lipids of mitochondria. Prog. Lipid Res. 2013;52:590–614. doi: 10.1016/j.plipres.2013.07.002. - DOI - PubMed
    1. Mejia E.M., Hatch G.M. Mitocho, ndrial phospholipids: role in mitochondrial function. J. Bioenerg. Biomembr. 2016;48:99–112. doi: 10.1007/s10863-015-9601-4. - DOI - PubMed
    1. Lu Y.W., Claypool S.M. Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes. Front. Genet. 2015;6:3. doi: 10.3389/fgene.2015.00003. - DOI - PMC - PubMed
    1. Ren M., Phoon C.K., Schlame M. Metabolism and function of mitochondrial cardiolipin. Prog. Lipid Res. 2014;55:1–16. doi: 10.1016/j.plipres.2014.04.001. - DOI - PubMed

LinkOut - more resources